
SIRT2-IN-9
SIRT2-IN-9
Catalog No. M35649
SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.
Size | Price / USD | Stock | Quantity |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 112 | Get Quote |
![]() ![]() |
25MG | 227 | Get Quote |
![]() ![]() |
50MG | 361 | Get Quote |
![]() ![]() |
100MG | 529 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSIRT2-IN-9
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Yang SY, Li LL. The purposes of 5H- [1,2,4] triazine [5,6-b] indole derivatives of 3 substitutions. CN108309982A. 2017.
molnova catalog



related products
-
AK-7
A potent, selective and brain-permeable SIRT2 inhibitor with IC50 of 15.5 uM.
-
Tenovin-D3
A novel selective, small-molecule inhibitor of sirtuin SITR2 with IC50 of 21.8 uM.
-
BML-278
BML-278 is a SIRT1 activator with an EC150 of 1 μM. It increases H3K9 methylation and inhibits H3K9 acetylation in parental and maternal prokaryotes, improving early embryonic development.